Disability improvement as a clinically relevant outcome in clinical trials of relapsing forms of multiple sclerosis

BACKGROUND: Disease-modifying therapies (DMTs) can reduce the risk of disability worsening in patients with relapsing forms of multiple sclerosis (RMS). High-efficacy DMTs can lead to confirmed or sustained disability improvement (CDI and SDI). OBJECTIVE AND METHODS: Post hoc analyses of data from t...

Descripción completa

Detalles Bibliográficos
Autores principales: Cree, Bruce AC, Cohen, Jeffrey A, Reder, Anthony T, Tomic, Davorka, Silva, Diego, Piani Meier, Daniela, Laflamme, Annik K, Ritter, Shannon, Leppert, David, Kappos, Ludwig
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597182/
https://www.ncbi.nlm.nih.gov/pubmed/33769117
http://dx.doi.org/10.1177/13524585211000280

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597182/
https://www.ncbi.nlm.nih.gov/pubmed/33769117
http://dx.doi.org/10.1177/13524585211000280

Ejemplares similares